Printer Friendly

COMPANY INFORMATION
Dragon Pharmaceutical, Inc. 310-650 Georgia St W Vancouver, BC V6B 4N9 Tel: (604) 669-8817 Toll-free: (877) 388-3784 Fax: (604) 669-4243 Contact Name Manager, Investor Relations Industry Pharmaceuticals		Key Executives Yanlin Han, CEO Garry Wong, CFO Produces pharmaceutical products at three facilities in Datong, People's Republic of China.
FP ADVISOR COVERAGE Dragon Pharmaceutical, Inc. • FP Corporate Analyzer • FP Corporate Surveys • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 5/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/DDD $0.69 $0.90 $0.50 n.a. n.a. n.a. 0.7 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 10,093 7.10 US$0.09 Sept. 30/09 4.55% 25.99% -11.63% $46,276
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08A 12m Dec. 31/07A 12m Dec. 31/06A US$000s US$000s US$000s Operating revenue 151,947 85,782 54,866 Net income 6,824 2,501 4,535 Total assets 148,375 114,477 83,972 US$ US$ US$ Earnings per share* 0.10 0.04 0.07 % % % Return on equity 11.57 11.42 (1.68)   * Common A Reported in accordance with U.S. GAAP
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09A Sept. 30/08A US$000s US$000s Operating revenue 155,050 163,402 Net income 6,578 7,137 US$ US$ Earnings per share 0.09 0.11   A Reported in accordance with U.S. GAAP

COMPANY NEWS

Results for 'Dragon Pharmaceutical, Inc.' from past 30 days: No hits. (Links are to articles.)